Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis.

NCT00151944 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Colitis, Ulcerative

Interventions

DRUG: SPD476 (mesalazine)

Sponsor

Shire